PUBLISHER: BCC Research | PRODUCT CODE: 1986234
PUBLISHER: BCC Research | PRODUCT CODE: 1986234
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
The North American market for infusion pumps and devices is expected to grow from $4.1 billion in 2025 and is projected to reach $5.9 billion by the end of 2030, at a CAGR of 7.4% during the forecast period of 2025 to 2030.
The European market for infusion pumps and devices is expected to grow from $2.7 billion in 2025 and is projected to reach $3.9 billion by the end of 2030, at a CAGR of 7.9% during the forecast period of 2025 to 2030.
This report provides an overview of the global infusion pumps and devices market and analyzes its trends.
The report includes global revenue (in millions of dollars), with 2024 as the base year, estimates for 2025, and forecasts through 2030. The market is segmented by product, applications, end user, and region. Based on the product, infusion pumps are categorized into general-purpose (large volume, syringe, electronic ambulatory, and elastomeric) and specialty types (insulin, enteral, and implantable infusion pumps). The report excludes consumables, accessories, and software systems used for infusion. The regions covered in this study are North America, Europe, Asia-Pacific (APAC), South America, and the Middle East and Africa (MEA), with a focus on major countries in each region.
The report focuses on significant trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.
The market analysis covers the distribution of infusion pumps and devices to various end users, including hospitals, home care, and alternate-site care settings.
The report concludes with an analysis of the competitive landscape, which provides the ranking and share of key businesses in the global infusion pumps and devices market. There is also a dedicated section of company profiles that covers details of leading businesses, such as BD (Becton, Dickinson and Company), Baxter, B. Braun SE, Medtronic, Insulet Corp., AVNS, Cardinal Health, Eitan Medical, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, ICU Medical Inc., Moog Inc., Tandem Diabetes Care Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., and Terumo Corp.